CRISPR-Cas9 Gene editing system, non-complex technology; complex patenting
Practices:Patents
Category:Others
| Authors | YAMAMOTO, Osamu |
|---|---|
| Practice Areas | Patents |
| Date of publication | Issue 3 2020 |
| Publication carrying this article | The Life Sciences Lawyer |
| Publisher | CTC Legal Media |
Summary
Mr. Yamamoto analyzes the patents in Japan on CRISPR-Cas9 Gene editing system, including the Intellectual Property High Court decisions on the two patent applications of Broad et al. rendered on February 25, 2020.
Other works by YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
The gray area between patent rights and physician practice
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
Antibody Patenting – Second Edition –
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Pharmaceutical Test Data Exclusivity
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
IP law in Japan : the recent changes
YAMAMOTO, Osamu
-
Publications
2022 – Study Question “Patentability of Diagnostic Methods”
YAMAMOTO, Osamu
Other works on Patents
-
Publications Intellectual Property、Patents Cases
The gray area between patent rights and physician practice
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Article 102(2) of the Patent Act – The Necessity of Sale of Competitive Products by Patentees
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents Laws
The Effect of an Invention
FUKAI, Toshiyuki
-
Publications Copyright Law、Intellectual Property、Patents、Trademarks
Q&A Practice for Prevention and Treatment of Intellectual Property Troubles “Cross License Agreements – Strategic Use and Legal Considerations “
SUMITANI, Yuji
-
Publications Intellectual Property、Patents Laws
Damage Claims for Patent Infringement by a Patentee’s Group Company
FUKAI, Toshiyuki
Telephone
+81(3)3270-6641